[Federal Register Volume 70, Number 2 (Tuesday, January 4, 2005)]
[Notices]
[Page 391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-74]



[[Page 391]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 21 CFR 1301.33(a), title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 2, 2004, Eli-
Elsohly Laboratories, Inc., Mahmoud A. Elsohly Ph.D., 5 Industrial Park 
Drive, Oxford, Mississippi 38655, made application by letter to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of Thebaine (9333), a basic class of controlled substance 
listed in Schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for use in analysis and drug test standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative, 
Office of Liaison and Policy (ODLR) and must be filed no later than 
March 7, 2005.

    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-74 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P